INBAKICEPT
UNII QN4LI58PJ5

Substance Identification & Data

This profile provides standardized clinical and technical data for Inbakicept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QN4LI58PJ5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2135939-52-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QN4LI58PJ5

CAS Registry Number

2135939-52-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INBAKICEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C177093

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

381609273

Unique identification number in the NCBI database of chemical substances.

INN ID

11029

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

GH-158

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Inbakicept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

INBAKICEPT

Common Names & Synonyms

ALT-803 COMPONENT IL-15R.ALPHA.SU/FC FUSION PROTEIN

INBAKICEPT [INN]

INBAKICEPT [USAN]

INBAKICEPT [WHO-DD]

INTERLEUKIN 15 RECEPTOR .ALPHA. CHAIN (HUMAN SUSHI DOMAIN-CONTAINING FRAGMENT) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN FC FRAGMENT), DIMER

INTERLEUKIN 15 RECEPTOR SUBUNIT ALPHA (HUMAN IL15R.ALPHA.) (1-65)-PEPTIDE (SUSHI DOMAIN-CONTAINING) FUSION PROTEIN WITH HUMAN IMMUNOGLOBULIN G1 FC FRAGMENT (232 C-TERMINAL RESIDUES) (66-297) (HOMO SAPIENS IGHG1*01, HINGE (71-80), CH2 (81-190), CH3 (191-295), CHS (296-297)), (76-76':79-79')-BISDISULFIDE DIMER

N-803 COMPONENT IL-15R.ALPHA.SU/FC FUSION PROTEIN

External Clinical & Regulatory Resources

Previous UNIIQN4KWH46E2

Next UNIIQN4R1036VD